A randomized controlled trial of N-acetylcysteine in the treatment of early-onset preeclampsia: Study Protocol

Kehinde S Okunade, Adebola A Adejimi, Muisi A Adenekan, Iyabo Y Ademuyiwa, Hameed Adelabu, Fatimah M Habeebu-Adeyemi, Adaiah P Soibi-Harry, Ololade Onasanya · 2026

Read A randomized controlled trial of N-acetylcysteine in the treatment of early-onset preeclampsia: Study Protocol by Kehinde S Okunade, Adebola A Adejimi, Muisi A Adenekan, Iyabo Y Ademuyiwa, Hameed Adelabu, Fatimah M Habeebu-Adeyemi, Adaiah P Soibi-Harry, Ololade Onasanya (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0347695.txt.

Description

Preeclampsia, a dangerous blood pressure disorder of pregnancy, can worsen fast, and few treatments slow it. Kehinde S Okunade and colleagues present a trial plan, in PLOS One in 2026, testing whether a common antioxidant drug can delay that worsening in Lagos, Nigeria.

About one hundred fifty women diagnosed early, between roughly six and eight months of pregnancy, will take a daily tablet of the drug or a look-alike placebo alongside normal care. Neither patients nor staff will know who gets which. The main measure is how many days pass before the disease advances. Results are not yet available; the trial runs through 2028.

Catalog record

CREATORKehinde S Okunade, Adebola A Adejimi, Muisi A Adenekan, Iyabo Y Ademuyiwa, Hameed Adelabu, Fatimah M Habeebu-Adeyemi, Adaiah P Soibi-Harry, Ololade Onasanya
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34483
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0347695

Browse the full library · About the Tower of Babel